Literature DB >> 12568317

Detection of chromosomal imbalances in spinal meningiomas by comparative genomic hybridization.

Ali Arslantas1, Sevilhan Artan, Ulkü Oner, Ramazan Durmaz, Hamza Müslümanoglu, Metin Ant Atasoy, Nurettin Başaran, Eşref Tel.   

Abstract

Little is known about genetic mutations during the malignant progression of spinal meningiomas. This study investigated genomic changes across the entire genome in spinal meningioma samples to determine possible mechanism(s) of tumorigenesis. Paraffin-embedded tissue sections of 16 spinal meningiomas were analyzed by the comparative genomic hybridization (CGH) technique. Lymphocytes of the patients were evaluated as controls. Genomic change was detected in 11 samples. Complete or partial loss of chromosome 22 was the most commonly seen abnormality in eight cases. Chromosome losses on 1p, 9p, and 10q and gains on 5p and 17q were the other abnormalities. These changes are all frequently seen in meningiomas, but are mostly specific to atypical and anaplastic meningiomas. However, in the present study, copy number changes on chromosomes 9p (3 samples), 17q (2 samples), and 1p (2 samples) were seen even in the benign tumors. Our results suggest that in addition to the neurofibromatosis type 2 tumor suppressor gene, other cancer-related genes located on 1p, 9p, 10q, and 17q might be involved in the etiology of spinal meningiomas.

Entities:  

Mesh:

Year:  2003        PMID: 12568317     DOI: 10.2176/nmc.43.12

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  8 in total

Review 1.  Updates in the management of intradural spinal cord tumors: a radiation oncology focus.

Authors:  Rupesh Kotecha; Minesh P Mehta; Eric L Chang; Paul D Brown; John H Suh; Simon S Lo; Sunit Das; Haider H Samawi; Julia Keith; James Perry; Arjun Sahgal
Journal:  Neuro Oncol       Date:  2019-06-10       Impact factor: 12.300

2.  An unusual case of cervical clear-cell meningioma in pediatric age.

Authors:  Murat Vural; Ali Arslantaş; Evrim Ciftçi; Sevilhan Artan; Metin Ant Atasoy
Journal:  Childs Nerv Syst       Date:  2006-09-22       Impact factor: 1.475

3.  Genomic alterations in low-grade, anaplastic astrocytomas and glioblastomas.

Authors:  Ali Arslantas; Sevilhan Artan; Ulkü Oner; M Hamza Müslümanoglu; Muhsin Ozdemir; Ramazan Durmaz; Didem Arslantas; Murat Vural; Erhan Cosan; Metin Ant Atasoy
Journal:  Pathol Oncol Res       Date:  2007-03-27       Impact factor: 3.201

Review 4.  Recent advances in intradural spinal tumors.

Authors:  Muhammad M Abd-El-Barr; Kevin T Huang; Ziev B Moses; J Bryan Iorgulescu; John H Chi
Journal:  Neuro Oncol       Date:  2018-05-18       Impact factor: 12.300

Review 5.  Spinal cord tumours: advances in genetics and their implications for treatment.

Authors:  Patricia L Zadnik; Ziya L Gokaslan; Peter C Burger; Chetan Bettegowda
Journal:  Nat Rev Neurol       Date:  2013-03-26       Impact factor: 42.937

6.  Current knowledge on spinal meningiomas: a systematic review protocol.

Authors:  Victor Gabriel El-Hajj; Jenny Pettersson Segerlind; Gustav Burström; Erik Edström; Adrian Elmi-Terander
Journal:  BMJ Open       Date:  2022-06-23       Impact factor: 3.006

7.  Two predominant molecular subtypes of spinal meningioma: thoracic NF2-mutant tumors strongly associated with female sex, and cervical AKT1-mutant tumors originating ventral to the spinal cord.

Authors:  Lingyang Hua; Majd Alkhatib; Dino Podlesek; Leila Günther; Thomas Pinzer; Matthias Meinhardt; Silke Zeugner; Sylvia Herold; Daniel P Cahill; Priscilla K Brastianos; Erik A Williams; Victoria E Clark; Ganesh M Shankar; Hiroaki Wakimoto; Leihao Ren; Jiawei Chen; Ye Gong; Gabriele Schackert; Tareq A Juratli
Journal:  Acta Neuropathol       Date:  2022-08-09       Impact factor: 15.887

8.  Dorsal extradural meningioma: Case report and literature review.

Authors:  Soheila Raysi Dehcordi; Alessandro Ricci; Alessandro Chiominto; Danilo De Paulis; Hambra Di Vitantonio; Renato J Galzio
Journal:  Surg Neurol Int       Date:  2016-08-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.